Unbound MEDLINE

Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma. Pediatric blood & cancer [Pediatr Blood Cancer] Journal article

 
TitleAdministration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma.
Author(s)Bernhardt MB, Hicks MJ, Pappo AS 
InstitutionDepartment of Pharmacy, Texas Children's Hospital, Houston, Texas.
SourcePediatr Blood Cancer 2009 Sep 3.
AbstractMalignant melanoma is rare in pediatrics, and therapies for patients with disseminated disease have not been well studied. This report describes our experience with the use of high-dose interleukin 2 (aldesleukin, IL-2) in a 2-year-old child with metastatic melanoma and describes our approach for the administration of this agent to young patients. Pediatr Blood Cancer (c) 2009 Wiley-Liss, Inc.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19731326
  
Advertise on this site.